NASDAQ: VSTMVerastem Inc Stock Ownership - Who owns Verastem?
Insider buying vs selling
Have Verastem Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul A. Bunn | Director | 2025-10-09 | 8,333 | $9.06 | $75.50kSell |
| Daniel Calkins | Chief Financial Officer | 2025-09-24 | 25 | $9.23 | $230.75Sell |
| Daniel Calkins | Chief Financial Officer | 2025-09-22 | 57 | $9.08 | $517.56Sell |
| Brian M. Stuglik | Director | 2025-09-16 | 587 | $9.99 | $5.86kSell |
| Robert E. Gagnon | Director | 2025-09-16 | 281 | $9.99 | $2.81kSell |
| Dan Paterson | President and CEO | 2025-09-16 | 390 | $9.99 | $3.90kSell |
| Dan Paterson | President and CEO | 2025-08-06 | 1,332 | $5.81 | $7.74kSell |
| Daniel Calkins | Chief Financial Officer | 2025-06-23 | 25 | $4.71 | $117.75Sell |
| Daniel Calkins | Chief Financial Officer | 2025-06-20 | 4,110 | $5.13 | $21.08kSell |
| Dan Paterson | President and CEO | 2025-06-20 | 17,808 | $5.13 | $91.36kSell |
VSTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VSTM insiders and whales buy or sell their stock.
VSTM Shareholders
What type of owners hold Verastem Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 29.38% | 16,142,051 | $152.54M | Insider |
| Ridgeback Capital Investments LP | 18.32% | 10,068,243 | $95.14M | Insider |
| Rtw Investments LP | 7.74% | 4,251,616 | $40.18M | Institution |
| Balyasny Asset Management LP | 7.65% | 4,205,968 | $39.75M | Institution |
| Mpm Bioventures V LLC | 7.22% | 3,966,666 | $37.48M | Insider |
| Longwood Fund LP | 6.90% | 3,789,775 | $35.81M | Insider |
| Vanguard Group Inc | 6.23% | 3,423,617 | $32.35M | Institution |
| Bvf Inc | 6.20% | 3,404,425 | $32.17M | Institution |
| Nantahala Capital Management LLC | 5.38% | 2,954,735 | $27.92M | Institution |
| Blackrock Inc | 5.02% | 2,758,914 | $26.07M | Institution |
VSTM vs Biotech Stocks
Verastem Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.